Roche Holding AG (OTCMKTS:RHHBY) Holdings Decreased by Sky Investment Group LLC

Sky Investment Group LLC cut its holdings in shares of Roche Holding AG (OTCMKTS:RHHBY) by 24.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 20,473 shares of the company’s stock after selling 6,580 shares during the quarter. Sky Investment Group LLC’s holdings in Roche were worth $714,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Brooklyn Investment Group boosted its holdings in shares of Roche by 36.6% during the fourth quarter. Brooklyn Investment Group now owns 1,354 shares of the company’s stock worth $48,000 after purchasing an additional 363 shares during the period. Diversified Trust Co boosted its stake in shares of Roche by 1.2% during the 4th quarter. Diversified Trust Co now owns 60,453 shares of the company’s stock valued at $2,130,000 after buying an additional 711 shares during the period. Bard Financial Services Inc. grew its holdings in shares of Roche by 37.7% during the 4th quarter. Bard Financial Services Inc. now owns 110,850 shares of the company’s stock valued at $3,866,000 after acquiring an additional 30,350 shares in the last quarter. Confluence Investment Management LLC increased its stake in shares of Roche by 26.3% in the fourth quarter. Confluence Investment Management LLC now owns 13,981 shares of the company’s stock worth $488,000 after acquiring an additional 2,910 shares during the last quarter. Finally, IHT Wealth Management LLC purchased a new stake in shares of Roche during the third quarter worth $236,000.

Roche Stock Performance

Shares of OTCMKTS RHHBY opened at $36.35 on Tuesday. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.97 and a current ratio of 1.26. Roche Holding AG has a one year low of $29.20 and a one year high of $42.43. The business’s 50-day moving average price is $35.76 and its two-hundred day moving average price is $38.06.

Roche Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.